HIV-AIDS and Florida Prevention Programs
Monograph
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Course Summary
The human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV can significantly depress immune system function, leading progressively to AIDS. Antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV-1 infection and AIDS, enabling HIV-infected individuals to live longer and have an improved quality of life. Advancements in ART have allowed many patients with HIV to achieve viral suppression. Nevertheless, HIV and AIDS are still serious health problems requiring federal and state resources. The Omnibus AIDS Act, Florida, as amended, guides and mandates Florida healthcare clinicians in the areas of screening, diagnosing, and reporting HIV/AIDS under A Brief Legal Guide For Health Care Professionals. Florida law reflects existing recommendations by the Centers for Disease Control and Prevention and other national organizations concerned with HIV testing and methods to avoid disease transmission through voluntary testing.
Course Objectives
Meet the continuing education requirements of the Florida Administrative Code, Rule 64B16-26.103(1)(a)
Identify how HIV/AIDS is transmitted
Identify methods of prevention and precaution for HIV/AIDS transmission
Describe the types of co-occurring disorders that may be seen in patients diagnosed with HIV/AIDS
Describe the State of Florida law on HIV/AIDS and its impact on testing, including the offering of HIV testing to pregnant women
Describe the State of Florida law on reporting HIV/AIDS and partner notification
I. Introduction
II. Prevalence of HIV/AIDS
III. Types and Stages of HIV Infection
A. HIV-1 and HIV-2
B. Stages of HIV Infection
C. The Acute HIV Infection Stage
D. The Chronic HIV Infection Stage
E. AIDS
IV. HIV Transmission and Prevention
A. Sexual Transmission
B. Blood Transfusion Transmission
C. Needle Sharing
D. Occupational Exposure
E. Possible Exposure risks for Pharmacists and Technicians
F. SHEA Guidelines and the HIV-infected Healthcare Worker
G. Healthcare Worker to Patient HIV Transmission
H. Mother-to-Infant Transmission
V. Pre-Exposure Prophylaxis, ART and Other Preventions
A. Pre-exposure Prophylaxis
B. Case Study: Pre-Exposure Prophylaxis
VI. HIV Screening
A. Blood Test for Antibodies to HIV and HIV Antigen
B. Home Screening Tests
VII. State Regulations for HIV/AIDS Testing
VIII. AIDS and Co-occurring Disorders
A. Cardiovascular Disease
B. Pulmonary Disease
C. Neurological Disease
D. Oral Lesions
E. Liver Disease
F. Hematologic Disease
G. Endocrine Disease
H. Dermatological Disease
I. Neoplastic Disease
J. Genitourinary Disease
K. AIDS-defining Diseases
IX. Brief Overview of Antiretroviral Therapy
X. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in developing this activity: Jeff Goldberg, PharmD, BCPP, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
Rating: 5/5
Based on the ratings of 5 customers
- Target Audience: Pharmacist
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 9/8/2024
- Activity Expiration Date: 9/8/2025
- Activity Type: Knowledge
- UAN: 0669-0000-24-125-H02-P
- Topic: HIV/AIDS Therapy
- CeBroker Number: 20-1240632
Author:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.